Variant report

Variant	esv14942
Chromosome Location	chr2:112895791-112898036
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:110)
CpG islands
(count:245)
Chromatin interactive
region (count:1)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:110 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:112895253-112895857	HepG2	liver:	n/a	n/a
2	BACH1	chr2:112895514-112896107	H1-hESC	embryonic stem cell:	n/a	n/a
3	BRCA1	chr2:112895663-112895915	HepG2	liver:	n/a	n/a
4	CEBPB	chr2:112895060-112895831	HepG2	liver:	n/a	n/a
5	CHD2	chr2:112895839-112896039	HepG2	liver:	n/a	chr2:112895987-112895997
6	E2F6	chr2:112895661-112896090	A549	lung:	n/a	n/a
7	E2F6	chr2:112895759-112896103	A549	lung:	n/a	n/a
8	E2F6	chr2:112896131-112896466	A549	lung:	n/a	n/a
9	ELF1	chr2:112895157-112895831	HepG2	liver:	n/a	chr2:112895404-112895417 chr2:112895221-112895232
10	FOSL2	chr2:112896111-112897859	HepG2	liver:	n/a	n/a
11	HA-E2F1	chr2:112895057-112897038	MCF-7	breast:	n/a	n/a
12	HDAC2	chr2:112895313-112896148	HepG2	liver:	n/a	n/a
13	HEY1	chr2:112896122-112897947	HepG2	liver:	n/a	n/a
14	HEY1	chr2:112896114-112897850	HepG2	liver:	n/a	n/a
15	HEY1	chr2:112895030-112896104	HepG2	liver:	n/a	chr2:112895843-112895858
16	JUND	chr2:112897231-112897440	HepG2	liver:	n/a	n/a
17	JUND	chr2:112896468-112897676	HepG2	liver:	n/a	n/a
18	JUND	chr2:112896853-112897007	HepG2	liver:	n/a	n/a
19	JUND	chr2:112895374-112895846	H1-hESC	embryonic stem cell:	n/a	n/a
20	MAX	chr2:112894979-112896527	HepG2	liver:	n/a	n/a
21	MAX	chr2:112895629-112896477	ECC-1	luminal epithelium:	n/a	n/a
22	MAX	chr2:112894967-112896526	HepG2	liver:	n/a	n/a
23	MAX	chr2:112895066-112896120	HepG2	liver:	n/a	n/a
24	MAX	chr2:112895608-112896250	A549	lung:	n/a	n/a
25	MAX	chr2:112895702-112896238	A549	lung:	n/a	n/a
26	MAX	chr2:112895816-112896095	SK-N-SH	brain:	n/a	n/a
27	MAX	chr2:112895775-112896458	MCF-7	breast:	n/a	n/a
28	MAX	chr2:112895800-112896222	ECC-1	luminal epithelium:	n/a	n/a
29	MAZ	chr2:112895022-112896393	HepG2	liver:	n/a	n/a
30	MYBL2	chr2:112894896-112895820	HepG2	liver:	n/a	n/a
31	MYC	chr2:112897776-112897847	MCF-7	breast:	n/a	n/a
32	NFIC	chr2:112895195-112895825	HepG2	liver:	n/a	n/a
33	POLR2A	chr2:112894942-112895889	HepG2	liver:	n/a	n/a
34	POLR2A	chr2:112896128-112897923	HepG2	liver:	n/a	n/a
35	POLR2A	chr2:112895812-112895946	HUVEC	blood vessel:	n/a	n/a
36	POLR2A	chr2:112896279-112896314	MCF-7	breast:	n/a	n/a
37	POLR2A	chr2:112895721-112896077	HUVEC	blood vessel:	n/a	n/a
38	POLR2A	chr2:112895949-112896089	HUVEC	blood vessel:	n/a	n/a
39	POLR2A	chr2:112896806-112897019	Gliobla	brain:	n/a	n/a
40	POLR2A	chr2:112896198-112896262	MCF-7	breast:	n/a	n/a
41	POLR2A	chr2:112896262-112896276	HepG2	liver:	n/a	n/a
42	POLR2A	chr2:112895768-112896884	HepG2	liver:	n/a	n/a
43	POLR2A	chr2:112897723-112897925	ECC-1	luminal epithelium:	n/a	n/a
44	POLR2A	chr2:112896212-112896420	A549	lung:	n/a	n/a
45	POLR2A	chr2:112896218-112896472	HepG2	liver:	n/a	n/a
46	POLR2A	chr2:112896308-112896658	HepG2	liver:	n/a	n/a
47	POLR2A	chr2:112897193-112897880	A549	lung:	n/a	n/a
48	POLR2A	chr2:112896436-112897823	A549	lung:	n/a	n/a
49	POLR2A	chr2:112896389-112896422	MCF-7	breast:	n/a	n/a
50	POLR2A	chr2:112897498-112897998	Gliobla	brain:	n/a	n/a

(count:245 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:112896214-112896264	A549	lung:	n/a
2	chr2:112896214-112896264	A549	lung:	n/a
3	chr2:112896214-112896264	HL-60	blood:	n/a
4	chr2:112895793-112895843	AG09309	skin:	n/a
5	chr2:112895793-112895843	PrEC	prostate:	n/a
6	chr2:112896214-112896264	MCF10A-Er-Src	breast:	n/a
7	chr2:112896214-112896264	SKMC	muscle:	n/a
8	chr2:112895793-112895843	T-47D	breast:	n/a
9	chr2:112895809-112895859	AG04449	skin:	fetal
10	chr2:112896214-112896264	Caco-2	colon:	n/a
11	chr2:112895809-112895859	A549	lung:	n/a
12	chr2:112896151-112896201	H1-hESC	embryonic stem cell:	embryo
13	chr2:112896214-112896264	NHBE	bronchial:	n/a
14	chr2:112896151-112896201	U87	brain:	n/a
15	chr2:112895809-112895859	Jurkat	blood:	n/a
16	chr2:112895809-112895859	AG10803	skin:	n/a
17	chr2:112896214-112896264	AG04449	skin:	fetal
18	chr2:112895809-112895859	HCM	heart:	n/a
19	chr2:112896151-112896201	HepG2	liver:	n/a
20	chr2:112896214-112896264	GM12892	blood:	n/a
21	chr2:112895793-112895843	HCT-116	colon:	n/a
22	chr2:112896151-112896201	SK-N-SH_RA	brain:	n/a
23	chr2:112896214-112896264	HCT-116	colon:	n/a
24	chr2:112896151-112896201	HCF	heart:	n/a
25	chr2:112896214-112896264	GM06990	blood:	n/a
26	chr2:112895793-112895843	PANC-1	pancreas:	n/a
27	chr2:112896151-112896201	HNPCEpiC	eye:	n/a
28	chr2:112896151-112896201	AG04449	skin:	fetal
29	chr2:112895793-112895843	NHBE	bronchial:	n/a
30	chr2:112896214-112896264	HEEpiC	esophagus:	n/a
31	chr2:112895793-112895843	GM12878	blood:	n/a
32	chr2:112895793-112895843	SK-N-MC	brain:	n/a
33	chr2:112895809-112895859	AG09319	gingival:	n/a
34	chr2:112895809-112895859	HCT-116	colon:	n/a
35	chr2:112895793-112895843	HRE	kidney:	n/a
36	chr2:112895793-112895843	A549	lung:	n/a
37	chr2:112896151-112896201	HCT-116	colon:	n/a
38	chr2:112895793-112895843	H1-hESC	embryonic stem cell:	embryo
39	chr2:112895809-112895859	SKMC	muscle:	n/a
40	chr2:112895809-112895859	AG09309	skin:	n/a
41	chr2:112895809-112895859	U87	brain:	n/a
42	chr2:112895809-112895859	PrEC	prostate:	n/a
43	chr2:112896214-112896264	HNPCEpiC	eye:	n/a
44	chr2:112896214-112896264	GM12891	blood:	n/a
45	chr2:112895809-112895859	HepG2	liver:	n/a
46	chr2:112896151-112896201	HMEC	breast:	n/a
47	chr2:112896151-112896201	GM12891	blood:	n/a
48	chr2:112895793-112895843	HMEC	breast:	n/a
49	chr2:112896214-112896264	ovcar-3	ovarian:	n/a
50	chr2:112896151-112896201	AG10803	skin:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr2:112896674..112899558-chr2:113471538..113473155,2	K562	blood:

No data

Variant related genes	Relation type
FBLN7	TF binding region
FBLN7	CpG island

Extended variants
information (count: 112 )
Associated
traits (count: 66 )

Variant overlapped rSNPs/rCNVs (count:112 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs547187348	chr2:112895846-112895847	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
2	rs543549332	chr2:112895881-112895882	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs563226072	chr2:112895886-112895887	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs532202861	chr2:112895927-112895928	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs565793622	chr2:112896020-112896021	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs112372758	chr2:112896086-112896087	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs552805229	chr2:112896100-112896101	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs559954773	chr2:112896101-112896102	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs528831011	chr2:112896102-112896103	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs548581268	chr2:112896103-112896104	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs144500920	chr2:112896112-112896113	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs200254772	chr2:112896192-112896193	Bivalent/Poised TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs368237815	chr2:112896200-112896201	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs201931347	chr2:112896201-112896202	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs146063077	chr2:112896248-112896249	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs201573384	chr2:112896249-112896250	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs199704935	chr2:112896267-112896268	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs201429460	chr2:112896288-112896289	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs376542803	chr2:112896311-112896312	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs558344765	chr2:112896327-112896328	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs377478557	chr2:112896340-112896341	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs571894158	chr2:112896358-112896359	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs369264145	chr2:112896367-112896368	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs138471444	chr2:112896416-112896417	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs534944111	chr2:112896432-112896433	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs11273609	chr2:112896436-112896437	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs9752913	chr2:112896481-112896482	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs554563691	chr2:112896493-112896494	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs574413297	chr2:112896495-112896496	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs36123826	chr2:112896541-112896542	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs377673915	chr2:112896645-112896646	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs543057764	chr2:112896719-112896720	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs371191731	chr2:112896728-112896729	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs556866611	chr2:112896739-112896740	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs577032467	chr2:112896742-112896743	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs186497152	chr2:112896793-112896794	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs560020050	chr2:112896815-112896816	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs528695730	chr2:112896824-112896825	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs111214997	chr2:112896838-112896839	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs376981859	chr2:112896842-112896843	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs36228464	chr2:112896865-112896866	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs74182854	chr2:112896892-112896893	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs373752535	chr2:112896946-112896947	Bivalent/Poised TSS Active TSS Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs367924941	chr2:112897012-112897013	Bivalent/Poised TSS Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs542551902	chr2:112897035-112897036	Bivalent/Poised TSS Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs56242356	chr2:112897037-112897038	Bivalent/Poised TSS Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs537394233	chr2:112897039-112897040	Bivalent/Poised TSS Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs371736721	chr2:112897055-112897056	Bivalent/Poised TSS Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs374228484	chr2:112897108-112897109	Bivalent/Poised TSS Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs368472768	chr2:112897166-112897167	Bivalent/Poised TSS Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:66)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	17483303	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Myxofibrosarcoma	16751306	CNVD
Breast cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Mowat-Wilson syndrome	21572526	CNVD
Disorders of sex development	21048976	CNVD
epilepsy	18472482	CNVD
Ewing''s sarcoma	17952124	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
lymphocytic leukemia	21291569	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Colorectal cancer	16272173	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
myoclonus epilepsy	18472482	CNVD
Benign familial neonatal-infantile seizures	18472482	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Astrocytoma	22246337	CNVD
Myelofibrosis	22110671	CNVD
Ocular motor apraxia	21572526	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	21549014	CNVD
Idiopathic chronic pancreatitis	21549014	CNVD
Mental retardation	21549014	CNVD
Maculopathy	20981449	CNVD
Nephronophthisis	22470819	CNVD
Colorectal cancer	16912164	CNVD
Ischaemic stroke	16980335	CNVD
Acute myeloid leukemia	18000384	CNVD
Nephronophthisis	17901113	CNVD
small cell lung cancer	20016488	CNVD
Non-syndromic sensorineural hearing loss	19212409	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:379 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:112895000-112895800	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
2	chr2:112895000-112895800	Bivalent/Poised TSS	Primary B cells from cord blood	blood
3	chr2:112895000-112895800	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
4	chr2:112895000-112895800	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
5	chr2:112895000-112896000	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
6	chr2:112895000-112896000	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
7	chr2:112895000-112896000	Bivalent/Poised TSS	Rectal Smooth Muscle	rectum
8	chr2:112895000-112896000	Flanking Bivalent TSS/Enh	NHEK	skin
9	chr2:112895200-112895800	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
10	chr2:112895200-112895800	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
11	chr2:112895200-112895800	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
12	chr2:112895200-112895800	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
13	chr2:112895200-112895800	Flanking Bivalent TSS/Enh	Primary T helper cells PMA-I stimulated	--
14	chr2:112895200-112895800	Flanking Active TSS	Primary T helper 17 cells PMA-I stimulated	--
15	chr2:112895200-112895800	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin02	Skin
16	chr2:112895200-112895800	Flanking Bivalent TSS/Enh	Adipose Nuclei	Adipose
17	chr2:112895200-112895800	Flanking Active TSS	Brain Substantia Nigra	brain
18	chr2:112895200-112895800	Flanking Active TSS	Duodenum Mucosa	Duodenum
19	chr2:112895200-112895800	Flanking Bivalent TSS/Enh	Fetal Heart	heart
20	chr2:112895200-112895800	Flanking Bivalent TSS/Enh	Fetal Muscle Leg	muscle
21	chr2:112895200-112895800	Flanking Bivalent TSS/Enh	Skeletal Muscle Male	skeletal muscle
22	chr2:112895200-112895800	Flanking Bivalent TSS/Enh	HepG2	liver
23	chr2:112895200-112895800	Flanking Active TSS	NHDF-Ad	bronchial
24	chr2:112895200-112895800	Flanking Active TSS	Osteobl	bone
25	chr2:112895200-112896000	Flanking Bivalent TSS/Enh	Muscle Satellite Cultured Cells	--
26	chr2:112895200-112896000	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin03	Skin
27	chr2:112895200-112896000	Flanking Active TSS	Liver	Liver
28	chr2:112895200-112896000	Flanking Bivalent TSS/Enh	Skeletal Muscle Female	skeletal muscle
29	chr2:112895200-112896000	Flanking Active TSS	HUVEC	blood vessel
30	chr2:112895200-112896600	Bivalent/Poised TSS	Stomach Smooth Muscle	stomach
31	chr2:112895200-112897000	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
32	chr2:112895200-112898200	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
33	chr2:112895400-112895800	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
34	chr2:112895400-112895800	Flanking Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
35	chr2:112895400-112895800	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
36	chr2:112895400-112895800	Flanking Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
37	chr2:112895400-112895800	Flanking Bivalent TSS/Enh	Primary B cells from peripheral blood	blood
38	chr2:112895400-112895800	Flanking Bivalent TSS/Enh	Primary T cells from cord blood	blood
39	chr2:112895400-112895800	Flanking Bivalent TSS/Enh	Primary T cells fromperipheralblood	blood
40	chr2:112895400-112895800	Flanking Bivalent TSS/Enh	Primary T helper naive cells fromperipheralblood	blood
41	chr2:112895400-112895800	Flanking Bivalent TSS/Enh	Primary T helper cells fromperipheralblood	blood
42	chr2:112895400-112895800	Flanking Bivalent TSS/Enh	Primary T regulatory cells fromperipheralblood	blood
43	chr2:112895400-112895800	Flanking Bivalent TSS/Enh	Primary T killer naive cells fromperipheralblood	blood
44	chr2:112895400-112895800	Bivalent/Poised TSS	Primary T killer memory cells from peripheral blood	blood
45	chr2:112895400-112895800	Flanking Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
46	chr2:112895400-112895800	Flanking Bivalent TSS/Enh	Brain Hippocampus Middle	brain
47	chr2:112895400-112895800	Flanking Active TSS	Brain Inferior Temporal Lobe	brain
48	chr2:112895400-112895800	Flanking Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
49	chr2:112895400-112895800	Flanking Bivalent TSS/Enh	Fetal Adrenal Gland	Adrenal Gland
50	chr2:112895400-112895800	Flanking Bivalent TSS/Enh	Fetal Brain Female	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links